Xeris Biopharma Holdings, Inc. (XERS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1234950,
    "name": "Xeris Biopharma Holdings, Inc.",
    "stock_name": "Xeris Biopharma Holdings, Inc.",
    "full_name": "Xeris Biopharma Holdings, Inc.",
    "name_url": "stocks-analysis/xeris-biopharma-holdings-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.72",
    "chg": 0.25,
    "chgp": "3.86%",
    "dir": 1,
    "prev_price": "6.47",
    "mcapval": "1,254.70",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US98422E1038",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.77 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/xeris-biopharma-holdings-inc-1234950-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Xeris Biopharma Hits Day Low at $7.00 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-hits-day-low-at-700-amid-price-pressure-3680286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/XerisBiopharmaH_priceRelatedfactors_3680286.png",
        "date": "2025-11-07 16:44:24",
        "description": "Xeris Biopharma Holdings, Inc. has faced notable volatility, with a significant stock decline today. Despite recent challenges, the company has shown impressive annual growth of 136.5% and strong returns over the past three years. However, it also grapples with financial risks, including a negative book value."
      },
      {
        "title": "Xeris Biopharma Faces Weak Start with 15% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-faces-weak-start-with-15-gap-down-amid-market-concerns-3712469",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/XerisBiopharmaH_gapdown_3712469.png",
        "date": "2025-11-07 16:28:40",
        "description": "Xeris Biopharma Holdings, Inc. opened with a notable loss, reflecting a significant decline in its stock performance over the past day and month. Despite this downturn, technical indicators show mixed signals, while the company maintains a market capitalization of approximately USD 1,255 million and a high return on equity."
      },
      {
        "title": "Xeris Biopharma Hits New 52-Week High of $10.03, Up 314.66%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-hits-new-52-week-high-of-1003-up-31466-3659217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XerisBiopharmaH_priceRelatedfactors_3659217.png",
        "date": "2025-10-30 18:54:45",
        "description": "Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 10.03 on October 29, 2025, reflecting a 314.66% increase over the past year. The company, despite being loss-making, has shown strong financial metrics and a market capitalization of USD 1,255 million in the biotechnology sector."
      },
      {
        "title": "Xeris Biopharma Hits New 52-Week High of $9.48, Up 297% Year-Over-Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-hits-new-52-week-high-of-948-up-297-year-over-year-3649317",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XerisBiopharmaH_priceRelatedfactors_3649317.png",
        "date": "2025-10-27 17:05:27",
        "description": "Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 9.48 on October 24, 2025, reflecting a 296.98% increase over the past year. The company, with a market cap of USD 1,255 million, shows strong financial metrics despite being currently loss-making and lacking a dividend yield."
      },
      {
        "title": "Xeris Biopharma Hits Day High with 14.16% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-hits-day-high-with-1416-surge-in-stock-price-3626754",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XerisBiopharmaH_priceRelatedfactors_3626754.png",
        "date": "2025-10-16 19:08:34",
        "description": "Xeris Biopharma Holdings, Inc. has seen a notable rise in its stock price, reflecting strong performance in the pharmaceuticals sector. Over the past year, the company has achieved impressive returns, significantly outpacing the S&P 500. Despite challenges like a negative book value, recent quarterly results show positive growth."
      },
      {
        "title": "Xeris Biopharma Hits New 52-Week High of $9.29, Up 299.57%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-hits-new-52-week-high-of-929-up-29957-3626680",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XerisBiopharmaH_priceRelatedfactors_3626680.png",
        "date": "2025-10-16 18:30:57",
        "description": "Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 9.29 on October 15, 2025, marking a significant performance increase of 299.57% over the past year. The company, despite being unprofitable, boasts a market capitalization of USD 1,255 million and strong financial metrics in the biotechnology sector."
      },
      {
        "title": "Xeris Biopharma Reaches New 52-Week High of $8.51, Up 253%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-reaches-new-52-week-high-of-851-up-253-3595691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XerisBiopharmaH_priceRelatedfactors_3595691.png",
        "date": "2025-10-06 17:44:42",
        "description": "Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 8.51, reflecting a significant year-over-year performance increase. With a market capitalization of approximately USD 1,255 million, the company has notable financial metrics, including a high return on equity, despite currently being loss-making and not offering dividends."
      },
      {
        "title": "Xeris Biopharma Hits New 52-Week High of $8.35, Up 232.76%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xeris-biopharma-hits-new-52-week-high-of-835-up-23276-3552738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/XerisBiopharmaH_priceRelatedfactors_3552738.png",
        "date": "2025-09-22 18:26:36",
        "description": "Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 8.35 on September 19, 2025, reflecting a significant growth trajectory over the past year. The company, with a market capitalization of USD 1,255 million, operates in the Pharmaceuticals & Biotechnology sector and has a notable return on equity."
      },
      {
        "title": "Is Xeris Biopharma Holdings, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xeris-biopharma-holdings-inc-technically-bullish-or-bearish-3548578",
        "imagepath": "",
        "date": "2025-09-20 20:21:13",
        "description": "As of 1 August 2025, the technical trend for Xeris Biopharma Holdings, Inc. has changed from mildly bullish to bullish. The MACD is bullish on both the weekly and monthly time frames, while the Bollinger Bands also indicate a bullish stance in both periods. The daily moving averages are bullish, supporting the overall positive trend. However, the weekly RSI is bearish, which suggests some caution, and the Dow Theory shows no trend on the weekly but is mildly bullish on the monthly. \n\nIn terms of performance, Xeris has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 144.84% compared to the S&P 500's 12.22%, and a one-year return of 186.21% versus 17.14%. Overall, the current technical stance is bullish, albeit with some mixed signals in the indicators...."
      }
    ],
    "total": 16,
    "sid": "1234950",
    "stock_news_url": "https://www.marketsmojo.com/news/xeris-biopharma-holdings-inc-1234950"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Xeris Biopharma Hits Day Low at $7.00 Amid Price Pressure

2025-11-07 16:44:24

Xeris Biopharma Holdings, Inc. has faced notable volatility, with a significant stock decline today. Despite recent challenges, the company has shown impressive annual growth of 136.5% and strong returns over the past three years. However, it also grapples with financial risks, including a negative book value.

Xeris Biopharma Faces Weak Start with 15% Gap Down Amid Market Concerns

2025-11-07 16:28:40

Xeris Biopharma Holdings, Inc. opened with a notable loss, reflecting a significant decline in its stock performance over the past day and month. Despite this downturn, technical indicators show mixed signals, while the company maintains a market capitalization of approximately USD 1,255 million and a high return on equity.

Xeris Biopharma Hits New 52-Week High of $10.03, Up 314.66%

2025-10-30 18:54:45

Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 10.03 on October 29, 2025, reflecting a 314.66% increase over the past year. The company, despite being loss-making, has shown strong financial metrics and a market capitalization of USD 1,255 million in the biotechnology sector.

Xeris Biopharma Hits New 52-Week High of $9.48, Up 297% Year-Over-Year

2025-10-27 17:05:27

Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 9.48 on October 24, 2025, reflecting a 296.98% increase over the past year. The company, with a market cap of USD 1,255 million, shows strong financial metrics despite being currently loss-making and lacking a dividend yield.

Xeris Biopharma Hits Day High with 14.16% Surge in Stock Price

2025-10-16 19:08:34

Xeris Biopharma Holdings, Inc. has seen a notable rise in its stock price, reflecting strong performance in the pharmaceuticals sector. Over the past year, the company has achieved impressive returns, significantly outpacing the S&P 500. Despite challenges like a negative book value, recent quarterly results show positive growth.

Xeris Biopharma Hits New 52-Week High of $9.29, Up 299.57%

2025-10-16 18:30:57

Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 9.29 on October 15, 2025, marking a significant performance increase of 299.57% over the past year. The company, despite being unprofitable, boasts a market capitalization of USD 1,255 million and strong financial metrics in the biotechnology sector.

Xeris Biopharma Reaches New 52-Week High of $8.51, Up 253%

2025-10-06 17:44:42

Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 8.51, reflecting a significant year-over-year performance increase. With a market capitalization of approximately USD 1,255 million, the company has notable financial metrics, including a high return on equity, despite currently being loss-making and not offering dividends.

Xeris Biopharma Hits New 52-Week High of $8.35, Up 232.76%

2025-09-22 18:26:36

Xeris Biopharma Holdings, Inc. achieved a new 52-week high of USD 8.35 on September 19, 2025, reflecting a significant growth trajectory over the past year. The company, with a market capitalization of USD 1,255 million, operates in the Pharmaceuticals & Biotechnology sector and has a notable return on equity.

Is Xeris Biopharma Holdings, Inc. technically bullish or bearish?

2025-09-20 20:21:13

As of 1 August 2025, the technical trend for Xeris Biopharma Holdings, Inc. has changed from mildly bullish to bullish. The MACD is bullish on both the weekly and monthly time frames, while the Bollinger Bands also indicate a bullish stance in both periods. The daily moving averages are bullish, supporting the overall positive trend. However, the weekly RSI is bearish, which suggests some caution, and the Dow Theory shows no trend on the weekly but is mildly bullish on the monthly. In terms of performance, Xeris has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 144.84% compared to the S&P 500's 12.22%, and a one-year return of 186.21% versus 17.14%. Overall, the current technical stance is bullish, albeit with some mixed signals in the indicators....

View All News